BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11341504)

  • 1. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.
    Dempfle CE; Zips S; Ergül H; Heene DL;
    Thromb Haemost; 2001 Apr; 85(4):671-8. PubMed ID: 11341504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer.
    Dempfle CE; Zips S; Ergül H; Heene DL;
    Thromb Haemost; 2001 Nov; 86(5):1204-9. PubMed ID: 11816708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of a new rapid quantitative assay system for measurement of D-dimer in plasma and whole blood: PATHFAST D-dimer.
    Dempfle CE; Suvajac N; Elmas E; Borggrefe M
    Thromb Res; 2007; 120(4):591-6. PubMed ID: 17175010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Nieuwenhuizen W
    Thromb Haemost; 1997 May; 77(5):1031-3. PubMed ID: 9184423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of novel assays for the detection of crosslinked fibrin degradation products in whole blood by the agglutination of the red blood cells].
    Kuroso K; Isogai N; Koike K; Fukutake K; Fujimaki M
    Rinsho Byori; 1992 Dec; 40(12):1281-6. PubMed ID: 1307633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The harmonization of quantitative test results of different D-dimer methods.
    Meijer P; Kluft C
    Semin Vasc Med; 2005 Nov; 5(4):321-7. PubMed ID: 16302153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
    Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
    Brenner B; Francis CW; Marder VJ
    J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
    Hafter R; Schröck R; von Hugo R; Graeff H
    Scand J Clin Lab Invest Suppl; 1985; 178():137-44. PubMed ID: 3867114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.
    McCarron BI; Marder VJ; Francis CW
    Thromb Haemost; 1999 Dec; 82(6):1722-9. PubMed ID: 10613661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of D-dimer using a fiber optic biosensor.
    Rowe CA; Bolitho JS; Jane A; Bundesen PG; Rylatt DB; Eisenberg PR; Ligler FS
    Thromb Haemost; 1998 Jan; 79(1):94-8. PubMed ID: 9459331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of autoantibodies against fibrinogen and fibrin degradation products by enzyme-linked immunoassay.
    Whitaker AN; McFarlane JR; Rowe EA; Lee K; Masci PP
    Thromb Haemost; 1985 Feb; 53(1):80-5. PubMed ID: 3992524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer.
    Waser G; Kathriner S; Wuillemin WA
    Thromb Res; 2005; 116(2):165-70. PubMed ID: 15907532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE).
    Ghanima W; Sandset PM
    Thromb Res; 2007; 120(4):471-6. PubMed ID: 17161451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of pulmonary embolism using quantitative plasma D-dimer assays.
    Sijens PE; Oudkerk M
    Clin Lab; 2001; 47(7-8):321-6. PubMed ID: 11499792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis.
    Rowbotham BJ; Carroll P; Whitaker AN; Bunce IH; Cobcroft RG; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ
    Thromb Haemost; 1987 Feb; 57(1):59-61. PubMed ID: 3590082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.